Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 1
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mawamba v (1 results)?
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children.
Nampota-Nkomba N, Nyirenda OM, Mapemba V, Masonga R, Patel PD, Misiri T, Mwakiseghile F, Wachepa R, Ndaferankhande JM, Lipenga B, Patel P, Banda H, Oshinsky J, Pasetti MF, Heyderman RS, Jamka LP, Hosangadi D, Datta S, Gordon MA, Neuzil KM, Laurens MB. Nampota-Nkomba N, et al. Among authors: mapemba v. Hum Vaccin Immunother. 2024 Dec 31;20(1):2384760. doi: 10.1080/21645515.2024.2384760. Epub 2024 Sep 12. Hum Vaccin Immunother. 2024. PMID: 39263923 Free PMC article. Clinical Trial.
Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children.
Nampota-Nkomba N, Nyirenda OM, Datta S, Mapemba V, Patel PD, Misiri T, Mwakiseghile F, Ndaferankhande JM, Lipenga B, Oshinsky J, Pasetti MF, Jamka LP, Gordon MA, Laurens MB, Neuzil KM; TyVAC team. Nampota-Nkomba N, et al. Among authors: mapemba v. EClinicalMedicine. 2025 Feb 12;81:103100. doi: 10.1016/j.eclinm.2025.103100. eCollection 2025 Mar. EClinicalMedicine. 2025. PMID: 40034570 Free PMC article.
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial.
Nampota-Nkomba N, Nyirenda OM, Khonde L, Mapemba V, Mbewe M, Ndaferankhande JM, Msuku H, Masesa C, Misiri T, Mwakiseghile F, Patel PD, Patel P, Johnson-Mayo I, Pasetti MF, Heyderman RS, Tracy JK, Datta S, Liang Y, Neuzil KM, Gordon MA, Laurens MB; Typhoid Vaccine Acceleration Consortium team. Nampota-Nkomba N, et al. Among authors: mapemba v. Lancet Glob Health. 2022 Sep;10(9):e1326-e1335. doi: 10.1016/S2214-109X(22)00275-3. Lancet Glob Health. 2022. PMID: 35961356 Free PMC article. Clinical Trial.
Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children.
Patel PD, Liang Y, Meiring JE, Chasweka N, Patel P, Misiri T, Mwakiseghile F, Wachepa R, Banda HC, Shumba F, Kawalazira G, Dube Q, Nampota-Nkomba N, Nyirenda OM, Girmay T, Datta S, Jamka LP, Tracy JK, Laurens MB, Heyderman RS, Neuzil KM, Gordon MA; TyVAC team. Patel PD, et al. Lancet. 2024 Feb 3;403(10425):459-468. doi: 10.1016/S0140-6736(23)02031-7. Epub 2024 Jan 25. Lancet. 2024. PMID: 38281499 Free PMC article. Clinical Trial.
The effect of environment and in-utero HIV exposure on neurodevelopment in infants.
Buchwald AG, Crespo-Llado MM, Maliwichi L, Mdhluli C, Mapemba V, Chifumbi S, Funsani M, Kalengo C, Hancock GR, Laufer MK, Gladstone M; REFINE research team. Buchwald AG, et al. Among authors: mapemba v. AIDS. 2025 Aug 1;39(10):1441-1451. doi: 10.1097/QAD.0000000000004217. Epub 2025 May 12. AIDS. 2025. PMID: 40265614 Free PMC article.